Good evening and welcome to Markets Desk, your end-of-week wrap from the floor.
Treasury yields are commanding attention, with strategists now openly discussing a path toward seven percent on the long end. That kind of move reshapes the calculus across equities, pressuring rate-sensitive sectors while energy names increasingly look like a defensive alternative to the crowded artificial intelligence trade.
Shifting to pharma, Asahi Kasei scored a meaningful regulatory win this week as the FDA approved HOVILPRI, its pritelivir tablet, for drug-resistant herpes simplex virus in immunocompromised adults. This is a niche but underserved patient population, and the approval gives Asahi Kasei's specialty therapeutics arm a genuine commercial foothold in the U.S. market.
And in crypto, the fallout from suspected Ledger hardware wallet thefts is now approaching ninety million dollars, with Tether moving to freeze stolen stablecoin linked to the incident. The breach is tied to an authorized reseller in Southeast Asia, and it raises uncomfortable questions about supply chain integrity in the hardware wallet space, an area investors had largely considered the safer end of crypto custody.
That's the tape. Markets Desk, signing off the floor.
